< Back to Previous Page
FDA Updates its Nationwide Alert on Counterfeit One Touch Blood Glucose Test Strips
The U.S. Food and Drug Administration (FDA) is providing an update to its notifications on October 13, and October 23, 2006, alerting the public to counterfeit blood glucose test strips being sold in the US for use with various models of LifeScan, Inc., One Touch Brand Blood Glucose Monitors. These test strips are used by people with diabetes to measure their blood glucose. Today’s update includes an additional lot number that is being distributed, along with a description of how to identify the new lot.
FDA has classified the current situation as a Class I recall because some of the counterfeit products have significant deviations in performance. The counterfeit test strips potentially could give incorrect blood glucose values-- either too high or too low--which might result in a patient taking either too much or too little insulin and lead to serious injury or death.
The products of concern are counterfeit – they are not marketed or distributed by Lifescan, and Lifescan is not responsible for conducting the recall. Rather, firms that are distributing the counterfeit product are responsible for conducting the recall using corrective actions developed by Lifescan, with input from FDA. FDA continues to work with Lifescan and the distributors to ensure that counterfeit products are removed from the market.
For complete information on how to identify the counterfeit test strips, please check LifeScan’s web site at www.lifescan.com/company/about/press/counterfeit/.
|
